Organic Process Research and Development p. 849 - 857 (2015)
Update date:2022-08-28
Topics:
Zhai, Li-Hai
Guo, Li-Hong
Luo, Yang-Hui
Ling, Yang
Sun, Bai-Wang
The discovery and development of an efficient synthesis route to axinitib is reported. The first-generation route researched by Pfizer implemented two Pd-catalyzed coupling reactions as key steps. In this work, the development of Heck-type and C-S coupling reactions catalyzed by CuI is briefly described, using an economial and practical protocol. Aspects of this route, such as selecting optimal ligands, solvent, and other conditions, are discussed in detail. The scale-up experiment was carried out to provide more than 300 g of active pharmaceutical ingredients of axitinib in Form XLI with 99.9% purity in 39% yield. In short, we provide a new choice of synthesis route to axitinib, through two copper-catalyzed coupling reactions with good yield.
View MoreContact:+86-134-5286-9121
Address:Add: Wing Tuck Commercial Centre, 177-183 Wing Lok Street, Hong Kong,
Wuhan Sun-shine Bio-technology Corporation Limited
Contact:+862765522452
Address:武汉市东湖高新区高新二路388号生物医药加速器16栋501
Contact:86 311 85902108 / 85902109
Address:room 1001-1005 ,huanghe Road ,shijiazhuang ,China
Huangshi Meifeng Chemical Co.,ltd.
Contact:+86-714-6516706
Address:1941-4-3#,Hubin Avenue,Huangshi,Hubei,China
Contact:0086-357-6662688
Address:Zhaocheng town, Hongtong County, Linfen City, Shanxi Province
Doi:10.1134/S1070363218020251
(2018)Doi:10.1515/znb-2010-0217
(2010)Doi:10.1016/S0040-4020(01)00547-6
(2001)Doi:10.1248/cpb.37.502
(1989)Doi:10.1021/jo501282h
(2014)Doi:10.1016/S0040-4039(00)61423-5
(1993)